LHRH agonists and the prevention of breast and ovarian cancer.

Early age at natural menopause or bilateral ovariectomy substantially reduce a woman's lifetime risk of breast cancer. Reversible 'bilateral ovariectomy' can now in effect be achieved by 'high-dose' luteinising hormone releasing hormone (LHRH) agonists (LHRHAs). The harmful...

Descripción completa

Detalles Bibliográficos
Autores principales: Pike, M. C., Ross, R. K., Lobo, R. A., Key, T. J., Potts, M., Henderson, B. E.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1989
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2247357/
https://www.ncbi.nlm.nih.gov/pubmed/2679844

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2247357/
https://www.ncbi.nlm.nih.gov/pubmed/2679844

Ejemplares similares